Iranian Consortium of Dialysis (ICD Group) was created for the purposes of supporting and assisting ESRD patients by offering related dialysis products & services. ICD’s vision is to be a leader in medical services, to operate under international standards, enhance ESRD patient lives, and promote health through integrated medical care. Directing attention to supplying only the highest applicable quality of medical products in the field, the group designs, establishes, runs, educates, consults and manages dialysis centers across the country. The group also participates in related projects by conducting further epidemiology research and writing, publishing & distributing The Iranian Dialysis Magazine. Adding to the Iran’s knowledge base of this disease, the group hopes to promote primary, secondary, and tertiary prevention. The ICD group consists of nine Iranian medical companies, who all share the goal of serving and assisting ESRD patients while achieving the highest standards possible. These Companies include: MEDITECHSYS, PHARMED MEDICAL INDUSTRIES, SMARRT, NIXXAMED, NOVATIS TEB, MEDWAY TEB POUYAN, PHARMED PLAST POUYAN, MEDICINA, and NOVA PHARMED CHEMIA.